References
- Danduga RCSR, Dondapati SR, Kola PK, Grace L, Tadigiri RVB, Kanakaraju VK. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats. Biomed Pharmacother. 2018;105:1254–68. doi: https://doi.org/10.1016/j.biopha.2018.06.079
- Sumathi T, Vedagiri A, Ramachandran S, Purushothaman B. Quinolinic acid-induced Huntington disease-like symptoms mitigated by potent free radical scavenger edaravone—a pilot study on neurobehavioral, biochemical, and histological approach in male Wistar rats. J Mol Neurosci. 2018;66(3):322–41. doi: https://doi.org/10.1007/s12031-018-1168-1
- Bates GP. The molecular genetics of Huntington disease—a history. Nat Rev Genet. 2005;6(10):766–73. doi: https://doi.org/10.1038/nrg1686
- Ambroziak W, Fourie C, Montgomery JM. SAP97-mediated rescue of NMDA receptor surface distribution in a neuronal model of Huntington’s disease. Hippocampus. 2018;28(10):707–23. doi: https://doi.org/10.1002/hipo.22995
- Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, et al. CAG Expansion in the Huntington disease gene is associated with a specific and targetable predisposing Haplogroup. Am J Hum Genet. 2009;84(3):351–66. doi: https://doi.org/10.1016/j.ajhg.2009.02.003
- Persichetti F, Srinidhi J, Kanaley L, Ge P, Myers RH, D’Arrigo K, et al. Huntington’s disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol Dis. 1994;1(3):159–66. doi: https://doi.org/10.1006/nbdi.1994.0019
- Chakraborty J, Pandey M, Navneet AK, Appukuttan TA, Varghese M, Sreetama SC, et al. Profilin-2 increased expression and its altered interaction with β-actin in the striatum of 3-nitropropionic acid-induced Huntington’s disease in rats. Neuroscience. 2014;281:216–28. doi: https://doi.org/10.1016/j.neuroscience.2014.09.035
- Choo YS. Mutant Huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet. 2004;13(14):1407–20. doi: https://doi.org/10.1093/hmg/ddh162
- Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH V. Mitochondrial defect in Huntington’s disease caudate nucleus. Ann Neurol. 1996;39(3):385–9. doi: https://doi.org/10.1002/ana.410390317
- Leegwater-Kim J, Cha J-HJ. The paradigm of Huntington’s disease: therapeutic opportunities in neurodegeneration. NeuroRX. 2004;1(1):128–38. doi: https://doi.org/10.1602/neurorx.1.1.128
- Malik J, Karan M, Dogra R. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism. Pharm Biol. 2017;55(1):980–90. doi: https://doi.org/10.1080/13880209.2017.1285945
- Gao Y, Chu S, Li J, Zhang Z, Yan J, Wen Z, et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease. Acta Pharmacol Sin. 2015;36(3):311–22. doi: https://doi.org/10.1038/aps.2014.107
- Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, et al. Effect of embelin against 3-nitropropionic acid-induced Huntington’s disease in rats. Biomed Pharmacother. 2016;77:52–8. doi: https://doi.org/10.1016/j.biopha.2015.11.009
- Ramachandran S, Thangarajan S. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington’s disease-like symptoms in Wistar rats. Chem Biol Interact. 2016;256:25–36. doi: https://doi.org/10.1016/j.cbi.2016.05.020
- Suganya SN, Sumathi T. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats. Metab Brain Dis. 2017;32(2):471–81. doi: https://doi.org/10.1007/s11011-016-9929-4
- Frank S. Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat. 2010;657:657–65. doi: https://doi.org/10.2147/NDT.S6430
- Claassen DO, Iyer RG, Shah-Manek B, DiBonaventura M, Abler V, Sung VW. Tetrabenazine treatment patterns and outcomes for chorea associated with Huntington disease: a retrospective chart review. J Huntingtons Dis. 2018;7(4):345–53. doi: https://doi.org/10.3233/JHD-170286
- Khalili-Fomeshi M, Azizi MG, Esmaeili MR, Gol M, Kazemi S, Ashrafpour M, et al. Piperine restores streptozotocin-induced cognitive impairments: insights into oxidative balance in cerebrospinal fluid and hippocampus. Behav Brain Res. 2018;337:131–8. doi: https://doi.org/10.1016/j.bbr.2017.09.031
- Umar S, Golam Sarwar AHM, Umar K, Ahmad N, Sajad M, Ahmad S, et al. Piperine ameliorates oxidative stress, inflammation and histological outcome in collagen induced arthritis. Cell Immunol. 2013;284(1–2):51–9. doi: https://doi.org/10.1016/j.cellimm.2013.07.004
- Shrivastava P, Vaibhav K, Tabassum R, Khan A, Ishrat T, Khan MM, et al. Anti-apoptotic and anti-inflammatory effect of piperine on 6-OHDA induced Parkinson’s Rat model. J Nutr Biochem. 2013;24(4):680–7. doi: https://doi.org/10.1016/j.jnutbio.2012.03.018
- Mao Q-Q, Huang Z, Ip S-P, Xian Y-F, Che C-T. Protective effects of piperine against corticosterone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32(4):531–7. doi: https://doi.org/10.1007/s10571-011-9786-y
- Andrabi SS, Parvez S, Tabassum H. Progesterone induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats. Dis Model Mech. 2017 Jun;10(6):787–96. doi: https://doi.org/10.1242/dmm.025692
- Rasheed MZ, Andrabi SS, Salman M, Tabassum H, Shaquiquzzaman M, Parveen S, et al. Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson’s disease. J Environ Pathol Toxicol Oncol. 2018;37(2):139–50. doi: https://doi.org/10.1615/JEnvironPatholToxicolOncol.2018025666
- Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington’s disease. CNS Neurosci Ther. 2014;20(1):10–9. doi: https://doi.org/10.1111/cns.12189
- Vishnoi S, Raisuddin S, Parvez S. Modulatory effects of an NMDAR partial agonist in MK-801-induced memory impairment. Neuroscience. 2015;311:22–33. doi: https://doi.org/10.1016/j.neuroscience.2015.10.008
- Ashafaq M, Tabassum H, Parvez S. Modulation of behavioral deficits and neurodegeneration by tannic acid in experimental stroke challenged Wistar rats. Mol Neurobiol. 2017;54(8):5941–51. doi: https://doi.org/10.1007/s12035-016-0096-8
- Khan M M, Raza SS, Javed H, Ahmad A, Khan A, Islam F, et al. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson’s disease. Neurotox Res. 2012;22(1):1–15. doi: https://doi.org/10.1007/s12640-011-9295-2
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54. doi: https://doi.org/10.1016/0003-2697(76)90527-3
- Tabassum H, Ashafaq M, Parvez S, Raisuddin S. Role of melatonin in mitigating nonylphenol-induced toxicity in frontal cortex and hippocampus of rat brain. Neurochem Int. 2017;104:11–26. doi: https://doi.org/10.1016/j.neuint.2016.12.010
- Ranju V, Sathiya S, Kalaivani P, Priya RJ, Saravana Babu C. Memantine exerts functional recovery by improving BDNF and GDNF expression in 3-nitropropionic acid intoxicated mice. Neurosci Lett. 2015;586:1–7. doi: https://doi.org/10.1016/j.neulet.2014.11.036
- Bak J, Kim HJ, Kim SY, Choi Y-S. Neuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicity. Korean J Physiol Pharmacol. 2016;20(3):279. doi: https://doi.org/10.4196/kjpp.2016.20.3.279
- Orozco-Ibarra M, García-Morales J, Calvo-Silva FJ, Fernández-Valverde F, Serrano-García N. Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment. Nutr Neurosci. 2018;21(2):132–42. doi: https://doi.org/10.1080/1028415X.2016.1237074
- Mahdy HM, Mohamed MR, Emam MA, Karim AM, Abdel-Naim A, Khalifa AE. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. Can J Physiol Pharmacol. 2014;92(3):252–8. doi: https://doi.org/10.1139/cjpp-2013-0398
- Leisman G, Braun-Benjamin O, Melillo R. Cognitive-motor interactions of the basal ganglia in development. Front Syst Neurosci. 2014;8:16. doi: https://doi.org/10.3389/fnsys.2014.00016
- Kumar P, Kalonia H, Kumar A. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington’s disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol. 2011;164:644–54. [ Br J Pharmacol. 2019;176(8):1170–1170]. doi: https://doi.org/10.1111/j.1476-5381.2011.01418.x
- Jamwal S, Kumar P. L-theanine, a Component of green tea prevents 3-nitropropionic acid (3-NP)-induced striatal toxicity by modulating nitric oxide pathway. Mol Neurobiol. 2017;54(3):2327–37. doi: https://doi.org/10.1007/s12035-016-9822-5
- Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM. Motor timing variability increases in preclinical Huntington’s disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc. 2007;13(03):539–43. doi: https://doi.org/10.1017/S1355617707070671
- Yohn CN, Gergues MM, Samuels BA. The role of 5-HT receptors in depression. Mol Brain. 2017;10(1):28. doi: https://doi.org/10.1186/s13041-017-0306-y
- Thangarajan S, Ramachandran S, Krishnamurthy P. Chrysin exerts neuroprotective effects against 3-nitropropionic acid induced behavioral despair—mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax—Bad genes in male Wistar rats. Biomed Pharmacother. 2016;84:514–25. doi: https://doi.org/10.1016/j.biopha.2016.09.070
- Verma MK, Goel R, Nandakumar K, Nemmani KVS. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala 2 GIP in rat model of Huntington’s disease. Eur J Pharmacol. 2018;828:31–41. doi: https://doi.org/10.1016/j.ejphar.2018.03.034
- Koch ET, Woodard CL, Raymond LA. Direct assessment of presynaptic modulation of cortico-striatal glutamate release in a Huntington’s disease mouse model. J Neurophysiol. 2018;120(6):3077–84. doi: https://doi.org/10.1152/jn.00638.2018
- Li K, Li J, Zheng J, Qin S. Reactive astrocytes in neurodegenerative diseases. Aging Dis. 2019;10(3):664. doi: https://doi.org/10.14336/AD.2018.0720
- Zhang S, Wu M, Peng C, Zhao G, Gu R. GFAP expression in injured astrocytes in rats. Exp Ther Med. 2017;14(3):1905–8. doi: https://doi.org/10.3892/etm.2017.4760
- Teunissen C, Steinbusch HW, Angevaren M, Appels M, de Bruijn C, Prickaerts J, et al. Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. Neuroscience. 2001;105(1):153–67. doi: https://doi.org/10.1016/S0306-4522(01)00164-6
- Wang H, Liu J, Gao G, Wu X, Wang X, Yang H. Protection effect of piperine and piperlonguminine from Piper longum L. alkaloids against rotenone-induced neuronal injury. Brain Res. 2016;1639:214–27. doi: https://doi.org/10.1016/j.brainres.2015.07.029
- Vaibhav K, Shrivastava P, Javed H, Khan A, Ahmed ME, Tabassum R, et al. Piperine suppresses cerebral ischemia–reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model. Mol Cell Biochem. 2012;367(1–2):73–84. doi: https://doi.org/10.1007/s11010-012-1321-z
- Jamwal DS, Singh J. Effects of piperine on enzyme activities and bioenergetic functions in isolated rat liver mitochondria and hepatocytes. J Biochem Toxicol. 1993;8(4):167–74. doi: https://doi.org/10.1002/jbt.2570080402